1 / 19

ECPC Collaborating for Cancer Patient Guidelines

Learn how the European Cancer Patient Coalition collaborates with scientific societies to produce cancer patient guidelines for timely and affordable access to treatment and care.

rjanet
Download Presentation

ECPC Collaborating for Cancer Patient Guidelines

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ECPC Initiatives: collaborating with scientific societies for the production of cancer patient guidelines Isabelle Manneh-Vangramberen, RPh. , MPH Head of EU Health and Research programmes European Cancer Patient Coalition (ECPC)

  2. Introduction • ECPC is the largest European cancer patients’ umbrella organizationrepresenting more than 400 organisations in 46 EU and non-EU countries. • Support capacity building efforts of ECPC member organizations (master-classes, advocacy tools, toolkits, advocacy information). • ECPC is the recognised voice of cancer patients in Europe: it is involved in all main table of discussions on cancer at the European level, including the European Commission’s Expert Group on Cancer Control, the Joint Action on Cancer Control, the Joint Action on Rare Cancers, the European reference networks, and the European Medicines Agency (EMA), among many others. ‘ Nothing about us.. without us! ’

  3. Main priorities = informs policy decisions • Direct link between research outcomes and concrete health policy choices. • Applying scientific results to healthy policy planningand the delivery of services.

  4. The European Cancer Patient Coalition (ECPC) works for a Europe of equality, where all European cancer patients have timely and affordable access to the best treatment and care available, throughout their life. • ECPC believes that cancer patients are the most important partners in the fight against cancer and against all the cancer-related issues affecting our society. • Policy makers, researchers, doctors and industry should recognise cancer patients as co-creators of their own health. • The European Cancer Patient Coalition draws on fundamental knowledge and understanding of the patients' situation by working through our Members. EU Health and Research programmes ECPC is one of the few patient organisations directly actively involved in design and implementation of EU-funded Health and Research projects.

  5. ECPC’s "on the field" engagement enhances our capacity to truly represent patients at the EU level, providing irreplaceable first-hand understanding of the issues revolving around cancer patients. • Furthermore, EU funded Health and Research projects allow us to be on the forefront of scientific developments on cancer by providing the patient's perspective while draining fundamental knowledge on the science behind cancer. • ECPC participates in the EU's Third Health Programme, as well as several European Union Research and Innovation framework programmes: this includes the Seventh Framework Programme (FP7) and Innovative Medicines Initiative (IMI) 1 and IMI 2 under Horizon 2020 (H2020).  • ECPC emphasises the importance of involving patients as co-researchers and strongly advocates for the best partnership model between both researchers and patients, allowing patients to contribute their unique experience working towards a more patient-centric study while participating in crucial project decisions.

  6. The European Cancer Patient Coalition (ECPC) and the European Society for Medical Oncology (ESMO) have signed a Memorandum of Understanding, with the aim of enhancing the existing cooperation and increasing the efforts to achieve their common goals and objectives in the field of cancer to satisfy the new needs and new rights of cancer patients across Europe. • The Memorandum establishes a legal framework for current and future collaborations, leaving complete freedom and discretion to the partners. In this respect, the Memorandum works alongside existing ECPC and ESMO agreements with third parties, avoiding duplication and enriching existing initiatives

  7. We are doing our part: • ECPC – ESMO Memorandum of Understanding signed in May 2016. • Not only formal agreement, but also practical collaboration on concrete projects: • - Update of the ESMO Guidelines • - Update of the Patients Guides • - Survivorship • The first topic on which ECPC and ESMO started collaborating was survivorship care. • ECPC is routinely and directly involved in the drafting of the Survivorship chapters of the new ESMO Clinical Practice Guidelines.

  8. ECPC and ESMO decided to partner up to include more patient-friendly and solid survivorship care provisions in the guidelines, reflecting cancer patients’ growing needs for structured follow up after the acute treatment phase. • In the coming years, each updated ESMO Guideline will contain a reviewed, patient-oriented survivorship chapter. • Check the ESMO Guides for Patients, an invaluable source of information. ECPC and ESMO will also ensure that the Guides for Patients will include updated provision on suvivorship care, in line with the Clinical Guidelines. • The Patient Guide on Survivorship was published in 2017. ESMO Patient Guides • The Memorandum formalises a long established partnership. • ECPC and ESMO have collaborated on a large range of  key policy issues related to cancer, including: Rare cancers: Data protection and Immuno-Oncology

  9. Survivorship is a unique and ongoing experience, which is different for each person and those close to them. • A key to survivorship is to regain, as far as possible, the important aspects of your life before cancer, and to find new pathways to a satisfactory life going forward. • Survivorship focuses on health and the physical, psychological, social and economic issues affecting people after the end of the primary treatment for cancer. • Survivorship care includes issues related to follow-up care, the management of late side-effects of treatment, the improvement of quality of life and psychological and emotional health. • Survivorship care includes also future anticancer treatment where applicable. Family members, friends and caregivers should also be considered as part of the survivorship experience. Survivorship Guide • The Patient Guide on Survivorship is created by ESMO and ECPC in collaboration with IPOS in order to help you and people like you at this important time in your life.

  10. In this guide you can find information on: • Support in coping with the new reality - Who can help me? • Life after initial treatment - How can I get my normal life back? • Preventive health - What lifestyle changes can I make to achieve optimal physical and emotional health? • Follow-up care: • Detection and management of treatment- or tumour-related symptoms • Prevention and detection of cancer recurrence • Prevention and early detection of new primary cancers for patients and their family members • Comorbidities and management of comorbidities • Keeping a personal health record / Survivorship care plan Survivorship Guide • Thee sections are followed with a possibility for personalised survivorship check list, care plan and treatment summary. • The final part of the Patient Guide is dedicated to a survivorship dictionary.

  11. In 2015 ECPC sent out an extensive survey on nutrition and its importance on the treatment and life of cancer patients. • The preliminary data obtained from the survey suggested that discrepancies still existed between patients’ expectations and the answers they may get from physicians about the metabolic and nutritional issues in cancer. • Building up on the pilot survey, in 2016 the European Cancer Patient Coalition continued its efforts with a second round of the survey in order to have enough data and maximise the impact of the answers received.

  12. ECPC European Survey • The new version of the 2016 survey was adapted in order to directly address individual cancer patients and cancer survivors. • It aimed to describeand understand the perception of the importance of metabolic and nutritional problems among patients and cancer survivors. The study was conducted by a survey of cancer patients and  survivors. • A structured questionnaire was designed to analyse the importance of nutrition for people with cancer. • A total 907 patients and survivors, distributed in 10 European countries (Finland, Italy, Spain, Czech Republic, Greece, Denmark, Slovenia, Romania, Poland, Bulgaria) answered the questionnaire.

  13. Survey Results • Results showed asubstantial gap in terms of need for information and practical management of cancer-related nutritional problems for people with cancer. • More than half of physicians (54.3%) did not pay attention to weight loss • Almost 2/3 of the patients (69.4%) knew that persistent loss of appetite could be caused by the tumour. • More than 70% of the participants experienced feeding problems during the disease and/or therapy and all the responders declared to be aware about feeding importance. • Almost 30% of the sample had no information on nutritional support, including artificial nutrition. • The majority of physicians (53.9%) did not check the nutritional status of their patients, including their body weight, or did not refer patients with feeding problems to a nutrition specialist.

  14. On the 9 November, 2017 MEP Daciana Octavia Sârbu (S&D, Romania) in collaboration with the European Cancer Patient Coalition (ECPC) hosted an event in the European Parliament on the important topic of the Role of Nutrition in Cancer Care. • The results of a study conducted by the European Cancer Patient Coalition (ECPC), Sapienza University of Rome, and Healthcare International to analyse the importance of nutrition for people with cancer was at the heart of today’s discussions following  an abstract of the study that was presented the European Society of Medical Oncology (ESMO) 2017 Congress in Madrid.

  15. Consultation Document • A Consultation Document was launched in November 2017 directed towards creating ECPC's Living Well During Cancer Treatment Booklet 2018. • The Document addresses common questions patents might have about diet, nutrition, and physical activity during treatment and provides general information regarding nutrition and cancer.

  16. Living Well Booklet • Endorsed by ESSO, and presented by EONS at ESMO 2018 Congress Nutrition Session. • The Living Well Booklet: addressing cancer patients' concerns is based on the ESPEN guidelines on nutrition in cancer patients and the ESMO Handbook of Nutrition and Cancer. • Contents: European Survey, Living Well, Screening, Body mass index, HSPH Nutrition Guide, WCRF/AICR Recommendations, 8 Questions to ask your Oncologist, Key Messages, a proposed Cancer Patient’s Charter of Rights for Appropriate and prompt nutritional Support, and Glossary.

  17. Living healthy during cancer treatments is a combination of good nutrition, which consists of an adequate and well balanced diet, and regular physical activity. However, the nutrient needs of each individual may vary, consult with your cancer care team can help you identify your nutrition goals. • It is not intended to offer medical advice orreplace advicegiven by your healthcare team.

  18. Thank you! Isabelle Manneh-Vangramberen, MPH, BPharma (ECPC) Head of Health and Research Programmes Email:isabelle.manneh-vgb@ecpc.org

More Related